Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin
Research output: Contribution to journal › Journal article › peer-review
Staphylococcus aureus survives inside eukaryotic cells. Our objective was to assess the activity of NZ2114, a novel peptidic antibiotic, against intracellular S. aureus in comparison with established antistaphylococcal agents acting on the bacterial envelope with a distinct mechanism.
Original language | English |
---|---|
Journal | Journal of Antimicrobial Chemotherapy |
Volume | 65 |
Issue number | 8 |
Pages (from-to) | 1720-4 |
Number of pages | 5 |
ISSN | 0305-7453 |
DOIs | |
Publication status | Published - 1 Aug 2010 |
- Anti-Bacterial Agents, Cell Line, Colony Count, Microbial, Daptomycin, Humans, Microbial Sensitivity Tests, Microbial Viability, Monocytes, Peptides, Staphylococcus aureus, Vancomycin
Research areas
ID: 33917973